RxDoctor Payments Data

Huai Phen, MD

Orthopaedic Trauma · Bronx, NYNPI 1548793185

Payments from drug & device makers

What this record shows

This record is dominated by education: $12,535 of the $13,879 with a category attached, or 90.3%. Smith+Nephew accounts for 92.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $6,730 and has fallen 98.1% since, to $131 in 2025.

$13,879in general payments, 2019–2025

Across 25 payments — averaging $555.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$13K
  • Stryker$822
  • Nuvasive Specialized Orthopedics, Inc.$99
  • Medical Device Business Services, Inc.$51
  • Gotham Surgical Solutions & Devices, Inc.$17

What the payments were for

  • Food & beverage$1,34410%
  • Education$12,53590%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,879 in reported general payments places this provider in the 70th percentile of 44 orthopaedic trauma providers in New York.

See all orthopaedic trauma providers in New York

Medicare billing

Part B allowed, 2024
$70,437
Medicare patients
120
Services billed
350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam50$109
Tramadol Hcl11$28
Oxycodone Hcl12$24

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →